Unlocking the Power of Proteomics with SPOC
Unlocking the Power of Proteomics with SPOC
SPOC Biosciences is Set to Revolutionize Proteomics with High Plex Protein Biosensor Platform
SPOC Biosciences is Set to Revolutionize Proteomics with High Plex Protein Biosensor Platform
SPOC Biosciences is pioneering a new era of proteomics with its innovative sensor-integrated proteome-on-chip (SPOC) technology. By offering unparalleled speed, scale, and data depth, SPOC is set to accelerate drug discovery, biomarker identification, and diagnostics.
SPOC Biosciences is pioneering a new era of proteomics with its innovative sensor-integrated proteome-on-chip (SPOC) technology. By offering unparalleled speed, scale, and data depth, SPOC is set to accelerate drug discovery, biomarker identification, and diagnostics.
About SPOC Biosciences
About SPOC Biosciences
SPOC Biosciences is a deep-tech life sciences startup that has developed a transformative new proteomic biosensor platform termed sensor-integrated proteome-on-chip (SPOC). SPOC Biosciences offers the world’s first and only platform that provides simultaneous quantitative, qualitative, and kinetic data in a single assay at scale, to support drug and vaccine development, protein biomarker discovery, and diagnostics.
SPOC Biosciences is a deep-tech life sciences startup that has developed a transformative new proteomic biosensor platform termed sensor-integrated proteome-on-chip (SPOC). SPOC Biosciences offers the world’s first and only platform that provides simultaneous quantitative, qualitative, and kinetic data in a single assay at scale, to support drug and vaccine development, protein biomarker discovery, and diagnostics.
7201 E Henkel Way Suite 285 Scottsdale, AZ 85255
7201 E Henkel Way Suite 285 Scottsdale, AZ 85255
About SPOC Proteomics
+2,400
+2,400
full-length folded proteins on 1.5 SQ-CM Biosensor Chip
full-length folded proteins on 1.5 SQ-CM Biosensor Chip
SPOC enables up to 2400 unique full-length folded proteins per single biosensor chip, for simultaneous analysis using surface plasmon resonance (SPR) and up to 10,000 protein targets per chip for mass spectrometry analysis. SPOC chip proteins are produced in ~4 hours from an array of plasmid DNA with cell-free human lysate and simultaneously captured directly onto biosensor chip surfaces.
SPOC enables up to 2400 unique full-length folded proteins per single biosensor chip, for simultaneous analysis using surface plasmon resonance (SPR) and up to 10,000 protein targets per chip for mass spectrometry analysis. SPOC chip proteins are produced in ~4 hours from an array of plasmid DNA with cell-free human lysate and simultaneously captured directly onto biosensor chip surfaces.
This unique protein production method circumvents challenges and expense of traditional recombinant protein workflows, reducing costs 10-100x and substantially decreasing production time. Our mission is to utilize SPOC to democratize high-throughput kinetic proteomic screens and facilitate early disease detection – ultimately enabling disease preemption.
This unique protein production method circumvents challenges and expense of traditional recombinant protein workflows, reducing costs 10-100x and substantially decreasing production time. Our mission is to utilize SPOC to democratize high-throughput kinetic proteomic screens and facilitate early disease detection – ultimately enabling disease preemption.
Meet our team
Meet our team
SPOC Biosciences is pioneering a new era of proteomics with its innovative sensor-integrated proteome-on-chip (SPOC) technology. By offering unparalleled speed, scale, and data depth, SPOC is set to accelerate drug discovery, biomarker identification, and diagnostics.
SPOC Biosciences is pioneering a new era of proteomics with its innovative sensor-integrated proteome-on-chip (SPOC) technology. By offering unparalleled speed, scale, and data depth, SPOC is set to accelerate drug discovery, biomarker identification, and diagnostics.
Leadership
Leadership
Bharath Takulapalli, PhD
Founder & CEO
Mukilan Mohan, MS MBA
Co-Founder & COO
Engin Yapici, PhD
VP of Business Development
Bharath Takulapalli, PhD
Founder & CEO
Mukilan Mohan, MS MBA
Co-Founder & COO
Engin Yapici, PhD
VP of Business Development
Board of directors and Scientific Advisory Board
Dr. George Church - Professor of Genetics
Harvard Medical School
Dr. Chenming Hu – Professor of EECS
University of California, Berkeley
Dr. Joshua LaBaer – Director, Center for Personalized Medicine
ASU Biodesign Institute
Dr. Abhay Sanan – President, Center for Neurosciences
Center for Neurosciences, Tucson
Jean Pierre Millon, MBA
DIRECTOR
Dr. George Church - Professor of Genetics
Harvard Medical School
Dr. Chenming Hu – Professor of EECS
University of California, Berkeley
Dr. Joshua LaBaer – Director, Center for Personalized Medicine
ASU Biodesign Institute
Dr. Abhay Sanan – President, Center for Neurosciences
Center for Neurosciences, Tucson
Jean Pierre Millon, MBA
DIRECTOR
Dr. George Church - Professor of Genetics
Harvard Medical School
Dr. Chenming Hu – Professor of EECS
University of California, Berkeley
Dr. Joshua LaBaer – Director, Center for Personalized Medicine
ASU Biodesign Institute
Dr. Abhay Sanan – President, Center for Neurosciences
Center for Neurosciences, Tucson
Jean Pierre Millon, MBA
DIRECTOR
For more information on the SPOC platform, get in touch:
Contact Us
1600 Adams Drive
Suite 236
Menlo Park, CA 94025
7201 E Henkel Way
Suite 285
Scottsdale, AZ 85255
480-219-9506
For more information on the SPOC platform, get in touch:
Contact Us
1600 Adams Drive
Suite 236
Menlo Park, CA 94025
7201 E Henkel Way
Suite 285
Scottsdale, AZ 85255
480-219-9506
Privacy & Conditions
All rights reserved © 2024
